Decoding Ashok Leyland & Indian Pharma Sector | Stoxpot #EP 8

In this episode of Stoxpot, Lekshman M J dives deep into the exciting developments shaping two major sectors in India—pharmaceuticals and commercial vehicles. Discover how the Indian pharma market is gearing up for an 8% growth in FY26, driven by new product launches, stable pricing, and strategic partnerships. Next, explore Ashok Leyland’s impressive quarterly performance, its push into electric vehicles, and how it’s capitalizing on government spending and export opportunities. Tune in for a detailed, story-driven analysis of what’s fueling these industries and what the future holds. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit lekshmanmj.substack.com